Evidence map›Paper›PMID 30452790›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2019

Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate.

André Raposo Moreira Dias, Arianna Pina, Amelia Dean, Hans-Georg Lerchen, Michele Caruso, Fabio Gasparri, Ivan Fraietta, Sonia Troiani, Daniela Arosio, Laura Belvisi and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Size-Dependent Cellular Uptake of RGD Peptides.Chembiochem : a European journal of chemical biology · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

André Raposo Moreira DiasUniversità degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi, 19, I-20133, Milan, Italy.ORCID http://orcid.org/0000-0001-6335-1156
Arianna PinaUniversità degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi, 19, I-20133, Milan, Italy.ORCID http://orcid.org/0000-0002-1644-8665
Amelia DeanUniversità degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi, 19, I-20133, Milan, Italy.
Hans-Georg LerchenMedicinal Chemistry Wuppertal, Bayer AG, 42113, Wuppertal, Germany.ORCID http://orcid.org/0000-0001-8746-9554
Michele CarusoNerviano Medical Sciences, Viale Pasteur, 10, I-20014, Nerviano, Italy.
Fabio GasparriNerviano Medical Sciences, Viale Pasteur, 10, I-20014, Nerviano, Italy.
Ivan FraiettaNerviano Medical Sciences, Viale Pasteur, 10, I-20014, Nerviano, Italy.
Sonia TroianiNerviano Medical Sciences, Viale Pasteur, 10, I-20014, Nerviano, Italy.
Daniela ArosioCNR, Istituto di Scienze e Tecnologie Molecolari (ISTM), Via C. Golgi, 19, I-20133, Milan, Italy.ORCID http://orcid.org/0000-0001-5486-3504
Laura BelvisiUniversità degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi, 19, I-20133, Milan, Italy.ORCID http://orcid.org/0000-0002-3593-2970
Luca PignataroUniversità degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi, 19, I-20133, Milan, Italy.ORCID http://orcid.org/0000-0002-7200-9720
Alberto Dal CorsoUniversità degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi, 19, I-20133, Milan, Italy.ORCID http://orcid.org/0000-0003-4437-8307
Cesare GennariUniversità degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi, 19, I-20133, Milan, Italy.ORCID http://orcid.org/0000-0002-7635-4900
University of Milan · ITNerviano Medical Sciences · ITInstitute of Molecular Science and Technologies · ITUniversity of Wuppertal · DE

Funding

Erasmus+European Commission MSCA-ITN MAGICBULLET 642004Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2015 project 20157WW5EHUniversità degli Studi di Milano
6 · The paper itself

Abstract

This work takes advantage of one of the hallmarks of cancer, that is, the presence of tumor infiltrating cells of the immune system and leukocyte-secreted enzymes, to promote the activation of an anticancer drug at the tumor site. The peptidomimetic integrin ligand cyclo(DKP-RGD) was found to accumulate on the surface of α

Indexed as

Antineoplastic Agents, PhytogenicCell Line, TumorCell ProliferationDrug LiberationHumansIntegrin alphaVbeta3Leukocyte ElastaseLigandsMicroscopy, ConfocalOligopeptidesPaclitaxelVitronectinAntineoplastic Agents, PhytogenicIntegrin alphaVbeta3Leukocyte ElastaseLigandsOligopeptidesPaclitaxelVitronectinantitumor agentsdrug deliveryelastaseinflammationneutrophils

Identifiers

PMID30452790
PMCPMC6471013
OpenAlexW2900586273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.